Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
about
Intensive care outcomes in adult hematopoietic stem cell transplantation patientsThe association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationTacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia.Accuracy of self-reported tobacco use status among hematopoietic SCT patients.Successful allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia during respiratory failure and invasive mechanical ventilation.The acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational study.Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantationLow risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networAn official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysisCarbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.Pretransplant lung function, respiratory failure, and mortality after stem cell transplantationPulmonary complications after hematopoietic stem cell transplantation.The effect of smoking on allogeneic transplant outcomes.Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.Oxygenation index predicts mortality in pediatric stem cell transplant recipients requiring mechanical ventilation.Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.Glutathione-S-transferase P1 may predispose children to a decline in pulmonary function after stem cell transplant.Adipose-derived stem cells extract has a proliferative effect on myogenic progenitors.The clinical value of biomarkers in respiratory complications in hematopoietic SCT.Pretransplant paranasal sinus disease is associated with a high incidence of transplant-related mortality in hematopoietic stem cell transplantation for children and adolescents.Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.Management of Acute Respiratory Failure in Patients With Hematological Malignancy.Pulmonary complications in hematopoietic SCT: a prospective study.Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.Influence of pretransplantation restrictive lung disease on allogeneic hematopoietic cell transplantation outcomes.MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.Should we T cell deplete sibling grafts for acute myeloid leukaemia in first remission?Respiratory failure after stem cell transplantation: improved outcome with non-invasive ventilation.Non-atopic IgE and eosinophil cationic protein after allogeneic hematopoietic stem cell transplantation in children.Identification and Characterization of a Dendritic Cell Precursor in Parenchymal Lung Tissue.Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.Tobacco smoking is associated with infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.
P2860
Q26767031-BED836FD-5B7F-47FC-B9E7-A0B2DFAC1081Q33760834-8B309661-06F0-4635-8DD8-0CC9F45EDDBEQ34077792-00591EDB-88F8-4112-BFE8-1D7A5CDEF1EFQ34104326-A9D0478D-93C8-41F1-AC3C-40A08FE12B35Q34172698-C3F0D7F7-5A24-4236-A2F2-CDED52C8968DQ34189131-53E7FABC-BD31-4FEE-8E35-3848934FEA23Q34545875-C2441DA6-4281-4E8D-85DE-A510ECB03E5DQ34805213-7E17D3BF-E46D-4AA0-A68B-AB8E5618721DQ35043175-FEBFA0BA-668D-4300-9886-8F80D279323BQ35148420-4076FD75-3555-446D-B777-A76400F055B6Q35694784-9FB0CBE7-18F0-48CD-982C-976CAF756079Q35750957-2A652A2B-853C-4A8D-BB88-56D0446E02E7Q36787274-E18AAF25-4284-4965-AD1D-FF0B2C4B210EQ37177449-9F485371-5205-4B38-BCD6-1538D48C00F6Q37184046-950EA9BF-B992-4BFF-B6A3-4C59EC98F4AEQ37282816-BCB33CAB-9FEC-4C5A-AD0D-FCC2880B3EDAQ37313313-BB560BA7-2E7E-4BB9-8938-CBC715411E3AQ37401674-42441469-2FAA-4A24-9E98-13A5D9955BC3Q37621636-45ACD2F2-7164-43DE-8423-9E7621DC2B03Q37680499-357A6DD7-21D1-4BF8-A5A1-8DD68E2F0AB6Q38019576-9C92A757-A8D1-454D-B366-CA89C68062BCQ38202155-8BEB3525-5262-4638-B064-D18EFFC75FF1Q38983999-22D0A9E7-85A1-4127-89CC-BEC96FAD8DD8Q39005711-2AB5DEAE-1881-4DB1-B6D5-E6F6C3F0D715Q40474709-51F2B73A-09DA-464E-AF9A-47881579750FQ40538822-A4C05B76-C04A-41B5-A2E5-02419D85166EQ40571851-EB529130-7F17-41B4-9AC2-F2AC1D836E38Q41047392-0AAA2AA7-967A-43A4-B710-AE35582DCC7CQ42204784-25F89204-DD87-4A6A-B463-76DEEAB12430Q42380314-10F1F595-BDBD-49DD-A732-334B29D39933Q42919707-5376A61E-41AB-41CF-9EE6-A457CC00F22AQ43169783-F64DB37E-EB72-43F1-982C-4CC9FBDC9BA5Q45174143-D8425248-E5F5-44C1-97AE-E3C1A95CA503Q46829240-E7A9DE0E-30EF-4439-B38A-CEAD73E4B54DQ47611845-792909FE-1381-4622-BCF6-0DA5EFEF39BDQ47751169-58B9A990-D702-4E06-B327-6407D18CF06AQ50791471-7238F697-E7B3-49D1-948E-2B2E924E58EBQ51364043-F0D00688-ECC7-4FBF-A894-2200C746A2A6Q51759896-04100939-4118-4C8D-A03A-E651B1BD6C74Q52942574-175E8BA6-F48C-492F-A30E-A27120F1399D
P2860
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prognostic factors for early s ...... tic stem cell transplantation.
@ast
Prognostic factors for early s ...... tic stem cell transplantation.
@en
Prognostic factors for early s ...... tic stem cell transplantation.
@nl
type
label
Prognostic factors for early s ...... tic stem cell transplantation.
@ast
Prognostic factors for early s ...... tic stem cell transplantation.
@en
Prognostic factors for early s ...... tic stem cell transplantation.
@nl
prefLabel
Prognostic factors for early s ...... tic stem cell transplantation.
@ast
Prognostic factors for early s ...... tic stem cell transplantation.
@en
Prognostic factors for early s ...... tic stem cell transplantation.
@nl
P2093
P1476
Prognostic factors for early s ...... tic stem cell transplantation.
@en
P2093
P304
P356
10.1053/BBMT.2001.V7.PM11349809
P577
2001-01-01T00:00:00Z